Lanean...
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
PURPOSE OF REVIEW: Compensatory mechanisms leading to increased androgen receptor expression and activity after androgen ablation or anti-androgen treatment have been identified in prostate cancer. After hydroxyflutamide and bicalutamide were used in therapy of prostate cancer over many years, novel...
Gorde:
| Argitaratua izan da: | Curr Mol Biol Rep |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700216/ https://ncbi.nlm.nih.gov/pubmed/29214142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40610-017-0079-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|